ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions

View by Date

Sunday, November 8, 2020

4:00PM-4:50PM: Abstract Number: 1516

The Value of Renal Biopsy at Lower Levels of Proteinuria in Patients Enrolled in the Lupus Accelerating Medicines Partnership

SLE – Diagnosis, Manifestations, & Outcomes III: Lupus Nephritis (1512–1516)

4:00PM-4:50PM: Abstract Number: 1495

Tofacitinib for the Treatment of Patients with Juvenile Idiopathic Arthritis: An Interim Analysis of Data up to 5.5 Years from an Open-label, Long-term Extension Study

Pediatric Rheumatology – Clinical I: Treatment of JIA (1492–1496)

4:00PM-4:50PM: Abstract Number: 1512

Trajectory Analysis of Repeat Renal Biopsies Identified Previous Endocapillary Proliferation as Predictor of Damage and End Stage Renal Disease in Pure Membranous Lupus Nephritis

SLE – Diagnosis, Manifestations, & Outcomes III: Lupus Nephritis (1512–1516)

4:00PM-4:50PM: Abstract Number: 1447

Vitamin D Deficiency Enhances Antiphospholipid Antibody-Mediated Thrombosis in a Passive Immunization Mouse Model

Antiphospholipid Syndrome (1447–1451)

5:00PM-5:50PM: Abstract Number: 1473

A Combination of Healthy Lifestyle Behaviors Reduce Risk of Incident Systemic Lupus Erythematosus in the Nurses’ Health Studies

Epidemiology & Public Health III: Risk Factors & Outcomes (1472–1476)

5:00PM-5:50PM: Abstract Number: 1521

A Novel Gut-joint Migratory TCRab+ Cell Subset Relies on sphingosine-1-phosphate for Tissue Localization

Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1517–1521)

5:00PM-5:50PM: Abstract Number: 1505

Antibodies Binding Ro/SSA and Muscarinic 3 Receptor in Sjogren’s Syndrome

Sjögren’s Syndrome (1502–1506)

5:00PM-5:50PM: Abstract Number: 1488

Application of the Knee Injury and Osteoarthritis Outcome Score Percentile Curves on Preoperative and up to 2 Years Postoperative Data of Patients Undergoing Total Knee Arthroplasty

Osteoarthritis II: Clinical Aspects (1487–1491)

5:00PM-5:50PM: Abstract Number: 1472

Assessing Causal Associations of Urate Levels with Type 2 Diabetes and Related Glycemic Traits Using Bidirectional Mendelian Randomization

Epidemiology & Public Health III: Risk Factors & Outcomes (1472–1476)

5:00PM-5:50PM: Abstract Number: 1491

Association of a Leaky Gut but Not Microbial Dysbiosis with Obesity-related OA: A Translational Study

Osteoarthritis II: Clinical Aspects (1487–1491)

5:00PM-5:50PM: Abstract Number: 1487

Biclustering Reveals Potential Knee Osteoarthritis Phenotypes in Exploratory Analyses: Data from the Osteoarthritis Initiative

Osteoarthritis II: Clinical Aspects (1487–1491)

5:00PM-5:50PM: Abstract Number: 1520

Characterisation of Rheumatoid and Psoriatic Arthritis Synovial Fibroblasts

Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1517–1521)

5:00PM-5:50PM: Abstract Number: 1502

Composite of Relevant Endpoints for Sjögren’s Syndrome (CRESS)

Sjögren’s Syndrome (1502–1506)

5:00PM-5:50PM: Abstract Number: 1506

Correction of Sjögren’s Syndrome Fluid Secretion Deficits in Salivary Gland Acinar Cells by Aquaporin-1 Gene Transfer

Sjögren’s Syndrome (1502–1506)

5:00PM-5:50PM: Abstract Number: 1474

Early Peak of Cardiovascular Events Occurs Equally in Caucasians and African-American SLE but Is Attributed to Different Risk Factors

Epidemiology & Public Health III: Risk Factors & Outcomes (1472–1476)

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].